Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine Updosing in Cold Contact Urticaria
NCT01271075Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Sep 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bilastine in cold urticaria, sponsored by Charité – Universitätsmedizin Berlin. Started Sep 2010; status: completed.
02
Drugs
bilastine
03
Conditions
cold urticaria
Beyond the preview
Go deeper on NCT01271075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01271075.